Award

Delivery Order #SPE2DR26FQX9A

Delivery Order Awarded to AmerisourceBergen for Diabetes Medication Supply

Buyer

Defense Logistics Agency

Award Amount

$13,312.38

Ceiling

$13,312.38

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Feb 27, 2026

Identifier

SPE2DR26FQX9A

NAICS

424210

This award represents a definitive delivery order contract that falls under a broader indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen Drug Corporation, a leading pharmaceutical services firm specializing in extensive drug distribution and supply chain management. The specific contract procures the medication Trulicity (1.5 mg/0.5 ml pen), used for managing diabetes, reflecting the agency's commitment to ensuring the availability of critical medications for healthcare services. The scope of work entails the delivery of this pharmaceutical product within a short, defined timeframe at Conshohocken, Pennsylvania. The contract was awarded as a fulfillment action under the existing IDV vehicle, indicating a non-competitive, follow-on procurement aligned with established agreements to maintain supply continuity. This arrangement is significant for supporting public health initiatives by guaranteeing access to essential diabetes treatment. Key subcontractors or original solicitation details were not disclosed for this particular delivery order. The timeline for this procurement is concise, covering a multi-day period, underscoring prompt fulfillment within the ongoing pharmaceutical supply program.

Description

4570968173!TRULICITY 1.5 MG/0.5 ML PEN 0.5ML

View original record